NCT04189445 2025-10-08Futibatinib in Patients With Specific FGFR AberrationsTaiho Oncology, Inc.Phase 2 Terminated115 enrolled 19 charts
NCT02052778 2025-03-27A Study of TAS-120 in Patients With Advanced Solid TumorsTaiho Oncology, Inc.Phase 1/2 Completed407 enrolled 45 charts 2 FDA